Eyecare Tech Inc

Eyecare Tech Inc has a debt-to-equity ratio of 0.61 and a current ratio of 0.94, indicating moderate leverage and liquidity constraints. The company's liquidity risk is rated as medium, with net cash negative after subtracting total debt. Free cash flow of TWD 54.9 million supports operational flexibility, but capital expenditures of TWD -62.7 million suggest ongoing investment in equipment leasing and surgical solutions. Profitability metrics show a return on equity of 28.19% and return on assets of 7.6%, outperforming the industry median for medical equipment firms in terms of asset efficiency. However, gross margin of 39.8% (TWD 261.1 million gross profit on TWD 656.5 million revenue) is in line with industry norms for surgical equipment distributors. The company's revenue is concentrated in Taiwan, with no disclosed international operations. Diagnostic equipment, phacoemulsification systems, and refractive laser centers represent key revenue segments, though segment-specific financials are not provided. This geographic and product concentration increases exposure to local healthcare policy shifts and surgical adoption rates. Outlook data is not provided, but historical revenue growth cannot be determined from the snapshot. The company's capital structure and cash flow suggest a stable but capital-intensive business model, with long-term debt of TWD 113.6 million and total liabilities of TWD 502.7 million. Risk factors include liquidity constraints and potential dilution from financial plans to support equipment leasing. No dilution risk is flagged in the current period, but the company's reliance on flexible financing could increase equity issuance pressure in the future. Recent filings do not disclose material events affecting operations or capital structure.